Almac Group is a global contract development and manufacturing organization (CDMO) providing an extensive range of integrated services to the pharmaceutical and biotech sectors. Founded in 1968, Almac offers services across the entire biopharmaceutical lifecycle, including R&D, biomarker discovery, API manufacture, formulation development, clinical trial supply, and commercial scale production. The company operates from headquarters in Northern Ireland and has facilities across Europe, the United States, and Asia, employing over 7,500 highly skilled staff.